当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 现金流量表

华兰生物

(002007)

  

流通市值:265.33亿  总市值:308.11亿
流通股本:15.74亿   总股本:18.27亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,017,751,654.45837,034,153.634,934,564,892.163,552,444,941.92
  收到的税费返还--10,763,868.93309,649.98
  收到其他与经营活动有关的现金31,682,074.4315,047,349.6968,051,640.9554,326,821.02
  经营活动现金流入小计2,049,433,728.88852,081,503.325,013,380,402.043,607,081,412.92
  购买商品、接受劳务支付的现金850,392,734.93416,525,887.581,655,884,984.831,553,707,874.46
  支付给职工以及为职工支付的现金259,013,142.67144,793,794.69478,493,657.33337,389,345.7
  支付的各项税费196,142,364.4596,652,099.95505,016,300.05342,011,232.97
  支付其他与经营活动有关的现金513,378,528.05179,931,139.391,314,640,297.95914,263,533.24
  经营活动现金流出小计1,818,926,770.1837,902,921.613,954,035,240.163,147,371,986.37
  经营活动产生的现金流量净额230,506,958.7814,178,581.711,059,345,161.88459,709,426.55
二、投资活动产生的现金流量:
  收回投资收到的现金7,405,875,686.754,251,514,785.5123,636,287,582.5317,901,290,166.75
  取得投资收益收到的现金96,651,869.8971,006,687.85135,294,495.93141,920,968.1
  处置固定资产、无形资产和其他长期资产收回的现金净额42,79225,712892,593.2769,072.52
  处置子公司及其他营业单位收到的现金净额--1,550,0001,550,000
  投资活动现金流入小计7,502,570,348.644,322,547,185.3623,774,024,671.6618,045,530,207.37
  购建固定资产、无形资产和其他长期资产支付的现金112,188,844.6867,866,067.66255,428,449.3457,425,868.78
  投资支付的现金6,882,517,908.44,611,335,357.2623,428,157,926.6117,569,564,573.61
  支付其他与投资活动有关的现金12,84012,840362,323.91-
  投资活动现金流出小计6,994,719,593.084,679,214,264.9223,683,948,699.8218,026,990,442.39
  投资活动产生的现金流量净额507,850,755.56-356,667,079.5690,075,971.8418,539,764.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金--16,281,00016,281,000
  取得借款收到的现金278,159,999.98278,704,844.44596,468,571.01300,000,000
  筹资活动现金流入小计278,159,999.98278,704,844.44612,749,571.01316,281,000
  偿还债务支付的现金819,380,000100,000,000700,000,000250,000,000.01
  分配股利、利润或偿付利息支付的现金386,700,910.797,612,869.43585,446,171.58586,908,790.4
  其中:子公司支付给少数股东的股利、利润56,360,006.6-117,616,500117,009,000
  支付其他与筹资活动有关的现金14,023,913.4-107,736,520.27107,167,606.39
  筹资活动现金流出小计1,220,104,824.1197,612,869.431,393,182,691.85944,076,396.8
  筹资活动产生的现金流量净额-941,944,824.1281,091,975.01-780,433,120.84-627,795,396.8
四、汇率变动对现金及现金等价物的影响189,692.0175,438.63-52,406.71-45,954.89
五、现金及现金等价物净增加额-203,397,417.77-261,321,084.21368,935,606.17-149,592,160.16
  加:期初现金及现金等价物余额1,358,260,221.681,358,260,221.68989,324,615.51989,324,615.51
  期末现金及现金等价物余额1,154,862,803.911,096,939,137.471,358,260,221.68839,732,455.35
补充资料:
  净利润522,691,390.04-1,155,469,792.25-
  资产减值准备-12,277,453.7-74,225,065.72-
  固定资产和投资性房地产折旧130,752,182.59-248,723,026.77-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧130,752,182.59-248,723,026.77-
  无形资产摊销6,096,426.39-11,732,164.68-
  长期待摊费用摊销2,944,181.02-11,314,041.8-
  处置固定资产、无形资产和其他长期资产的损失21,450.45--78,661.39-
  固定资产报废损失1,464,932.24-5,709,620.93-
  公允价值变动损失-12,504,878.82--32,940,014.29-
  财务费用4,560,270.78-13,124,519.99-
  投资损失-78,427,996.02--137,517,910.98-
  递延所得税-8,544,518.86-3,707,251.35-
  其中:递延所得税资产减少-8,608,932.01-6,385,601.46-
    递延所得税负债增加64,413.15--2,678,350.11-
  存货的减少-262,647,350.4--416,884,677.76-
  经营性应收项目的减少378,167,420.25-840,461,407.42-
  经营性应付项目的增加-413,062,669.54--723,825,743.11-
  其他5,527,310.88-11,084,642.93-
  现金的期末余额1,154,862,803.91-1,358,260,221.68-
  减:现金的期初余额1,358,260,221.68-989,324,615.51-
  现金及现金等价物的净增加额-203,397,417.77-368,935,606.17-
公告日期2025-08-282025-04-282025-03-292024-10-30
审计意见(境内)标准无保留意见
TOP↑